Showing results (111-120 of 1,748) with videos related to

Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
LF 15-0195 generates synergistic tolerance by promoting formation of CD4+CD25+CTLA4+ T cellsXiaoping Xia, Xiao Zhang, Xuyan Huang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effectsT Olencki, J Finke, R Tubbs, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptorE J Beecham, S Ortiz-Pujols, R P Junghans
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Anti-tumor vaccination in heterozygous congenic F1 mice: presentation of tumor-associated antigen by the two parental class I allelesL Carmon, E Tzehoval, B Tirosh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL responseM E Dudley, M I Nishimura, A K Holt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?R Hurst, D E White, J Heiss, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Human papillomavirus vaccines for cervical cancerM Murakami, K J Gurski, M A Steller
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression of HLA class 1, ICAM-1, and CD20 in vincristine-resistant hematologic cell linesM Hirose, S Hamano, K Tobinai, et al.
Pageof 175